Documents show Sackler family’s involvement in opioid operations

Katie Adams –
Wednesday, October 28th, 2020
Print|Email.

2 U.S. agents released files Oct. 27 detailing the Sackler familys role in opioid sales for Purdue Pharma, which the household owned until it concurred to dissolve the company in an agreement reached with the Department of Justice.

She launched the documents with fellow committee member Rep. Mark DeSaulnier, D-Calif.

She launched the documents with fellow committee member Rep. Mark DeSaulnier, D-Calif.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.

The files include slide decks, e-mails and financial charts that reveal how the Sackler household went about dealing with Purdue Pharmas opioid sales. According to Ms. Maloney and Mr. DeSaulnier, the Sackler family used Purdue Pharmas OxyContin company to extend financial targets and boost incomes, often goading executives to grow market share for the drug and other opioids by pursuing high-volume prescribers and advocating for greater strength doses.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material?

More short articles on opioids: Walmart pre-emptively sues United States as part of opioid litigation battleWest Virginia court orders Walmart to turn over opioid documentationPurdue Pharma to liquify, pay $8.3 B for role in opioid epidemic.

On Oct. 21, Purdue Pharma consented to close down its company, pay roughly $8.3 billion and plead guilty to three federal criminal charges for its function in exacerbating the country and developings opioid epidemic. Nevertheless, the ruling has been slammed by lawmakers and activists because it did not include criminal charges versus any Purdue Pharma executives or the Sackler relative.